Literature DB >> 9545096

A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes.

G Dewald1, R Stallard, A Al Saadi, S Arnold, P I Bader, R Blough, K Chen, B R Elejalde, C J Harris, R R Higgins, G A Hoeltge, W T Hsu, V Kubic, D J McCorquodale, M A Micale, J W Moore, R M Phillips, S Scheib-Wixted, S Schwartz, S Siembieda, K Strole, P VanTuinen, G H Vance, A Wiktor, A Zinsmeister.   

Abstract

Twenty-six laboratories used X and Y chromosome probes and the same procedures to process and examine 15,600 metaphases and 49,400 interphases from Phaseolus vulgaris-leucoagglutinin (PHA)-stimulated lymphocytes. In Part I, each laboratory scored 50 metaphases and 200 interphases from a normal male and a normal female from its own practice. In Part II, each laboratory scored 50 metaphases and 200 interphases on slides prepared by a central laboratory from a normal male and a normal female and three mixtures of cells from the male and female. In Part III, each laboratory scored 50 metaphases (in samples of 5, 10, 15, and 20) and 100 interphases (in samples of 5, 10, 15, 20, and 50) on new, coded slides of the same specimens used in Part II. Metaphases from male specimens were scored as 98-99% XY with no XX cells, and 97-98% of interphases were scored as XY with 0.04% XX cells. Metaphases from female specimens were scored as 96-97% XX with 0.03% XY cells, and 94-96% of interphases were scored as XX with 0.05% XY cells. Considering the data as a model for any probe used with fluorescence in situ hybridization (FISH), a statistical approach assessing the impact of analytical sensitivity on the numbers of observations required to assay for potential mosaicisms and chimerisms is discussed. The workload associated with processing slides and scoring 50 metaphases and 200 interphases using FISH averaged 27.1 and 28.6 minutes, respectively. This study indicates that multiple laboratories can test/develop guidelines for the rapid, efficacious, and cost-effective integration of FISH into clinical service.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545096

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

Review 1.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Guidance for fluorescence in situ hybridization testing in hematologic disorders.

Authors:  Daynna J Wolff; Adam Bagg; Linda D Cooley; Gordon W Dewald; Betsy A Hirsch; Peter B Jacky; Kathleen W Rao; P Nagesh Rao
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

3.  Chromosome arm-specific long telomeres: a new clonal event in primary chronic myelogenous leukemia cells.

Authors:  Oumar Samassekou; Huiyu Li; Josée Hébert; Aimé Ntwari; Haixia Wang; Catherine Grenier Cliché; Eric Bouchard; Shiang Huang; Ju Yan
Journal:  Neoplasia       Date:  2011-06       Impact factor: 5.715

4.  Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens.

Authors:  A J Dawson; J McGowan-Jordan; J Chernos; J Xu; J Lavoie; J C Wang; M Steinraths; S Shetty
Journal:  Curr Oncol       Date:  2011-10       Impact factor: 3.677

Review 5.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.

Authors:  Roland A Ventura; Jose I Martin-Subero; Margaret Jones; Joanna McParland; Stefan Gesk; David Y Mason; Reiner Siebert
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

6.  Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies.

Authors:  Roman Crazzolara; Gabriele Kropshofer; Michael Steurer; Sieghart Sopper; Wolfgang Schwinger
Journal:  J Vis Exp       Date:  2017-09-06       Impact factor: 1.355

7.  Standardization of fluorescence in situ hybridization studies on chronic lymphocytic leukemia (CLL) blood and marrow cells by the CLL Research Consortium.

Authors:  Stephanie A Smoley; Daniel L Van Dyke; Neil E Kay; Nyla A Heerema; Marie L Dell' Aquila; Paola Dal Cin; Prasad Koduru; Ayala Aviram; Laura Rassenti; John C Byrd; Kanti R Rai; Jennifer R Brown; Andrew W Greaves; Jeanette Eckel-Passow; Donna Neuberg; Thomas J Kipps; Gordon W Dewald
Journal:  Cancer Genet Cytogenet       Date:  2010-12

8.  The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues.

Authors:  Paulie Papavassiliou; Timothy P York; Nurcan Gursoy; Gloria Hill; Lauren Vanner Nicely; Usha Sundaram; Allison McClain; Steven H Aggen; Lindon Eaves; Brien Riley; Colleen Jackson-Cook
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

9.  Individual telomere lengths in chronic myeloid leukemia.

Authors:  Oumar Samassekou; Aimé Ntwari; Josée Hébert; Ju Yan
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

10.  One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection.

Authors:  Rima Tinawi-Aljundi; Lauren King; Shannon T Knuth; Michael Gildea; Carrie Ng; Josh Kahl; Jacqueline Dion; Chris Young; Edward W Schervish; J Rene Frontera; Jason Hafron; Kenneth M Kernen; Robert Di Loreto; Joan Aurich-Costa
Journal:  Res Rep Urol       Date:  2015-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.